Beta-Glucan 用于 Upper Respiratory Tract Infections
AMeta-analysis of 13 randomized controlled trials shows yeast beta-glucan may help reduce the incidence, number of episodes, and duration of upper respiratory tract infections compared to placebo. A 16-week RCT with 162 participants found 25% reduction in symptomatic cold infections.
结论
Meta-analysis of 13 randomized controlled trials shows yeast beta-glucan may help reduce the incidence, number of episodes, and duration of upper respiratory tract infections compared to placebo. A 16-week RCT with 162 participants found 25% reduction in symptomatic cold infections.
Key Study Findings
研究人群: None
研究人群: None
研究人群: Adults with Protective Qi deficiency
研究人群: healthy subjects
研究人群: URTI patients
研究人群: URTI patients
Key Statistics
13
研究数量
2000
受试者
Positive
等级
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- general:
- 250-500 mg/day
- immunesupport:
- 250-750 mg/day
上限: No established UL
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| 10 mg | -- | Positive | -- |
| 250 mg/d | -- | Positive | -- |
| None | 12 weeks | Positive | -- |
| 95% | -- | Positive | -- |
| 250 mL/d | -- | Mixed | 69 |
| 250 mL/d | -- | Neutral | 132 |
| 900 mg | 16.0 weeks | Positive | 299 |
| 367 mg | 12.9 weeks | Positive | 34 |
最佳服用时间: On empty stomach for optimal immune activation
Safety & Side Effects
已报告的副作用
- ⚠ Generally very well tolerated
- ⚠ Mild gastrointestinal effects (bloating)
- ⚠ Allergic reactions in yeast-sensitive individuals
已知相互作用
- ● Immunosuppressant medications (may counteract immunosuppression)
- ● Generally few known drug interactions
可耐受最高摄入量: No established UL
在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Beta-Glucan help with Upper Respiratory Tract Infections?
How much Beta-Glucan should I take for Upper Respiratory Tract Infections?
Are there side effects of Beta-Glucan?
How strong is the evidence for Beta-Glucan and Upper Respiratory Tract Infections?
Related Evidence
其他成分用于 Upper Respiratory Tract Infections
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。